Chemotherapy and radiotherapy use in patients with lung cancer in Australia, Canada, the UK and Norway 2012-2017: an ICBP population-based study.

Barclay ME, McPhail S, Johnson SA, Swann R, Finley CJ, Butler J, Alvi R, Barisic A, Bennett DB, Bucher O, Creighton N, Denny CA, Dewar RA, Donnelly DW, Dowden JJ, Downie L, Finn N, Habbous S, Huws DW, Kumar SE, May L, McClure CA, Møller B, Morrison DS, Musto G, Nilssen Y, Saint-Jacques N, Sarker S, Shack L, Te Marvelde L, Tian X, Thomas RJ, Thomson CS, Walton R, Wang H, Wong THT, Woods RR, You H, Zhang B, Lyratzopoulos G, ICBP Module 9 Lung Study Group.

Open source

DOI
10.1136/bmjonc-2025-000800
Published
2025-07-11
Container
BMJ Oncol
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/bmjonc-2025-000800,
  title = {Chemotherapy and radiotherapy use in patients with lung cancer in Australia, Canada, the UK and Norway 2012-2017: an ICBP population-based study.},
  author = {Barclay ME and  McPhail S and  Johnson SA and  Swann R and  Finley CJ and  Butler J and  Alvi R and  Barisic A and  Bennett DB and  Bucher O and  Creighton N and  Denny CA and  Dewar RA and  Donnelly DW and  Dowden JJ and  Downie L and  Finn N and  Habbous S and  Huws DW and  Kumar SE and  May L and  McClure CA and  Møller B and  Morrison DS and  Musto G and  Nilssen Y and  Saint-Jacques N and  Sarker S and  Shack L and  Te Marvelde L and  Tian X and  Thomas RJ and  Thomson CS and  Walton R and  Wang H and  Wong THT and  Woods RR and  You H and  Zhang B and  Lyratzopoulos G and  ICBP Module 9 Lung Study Group.},
  year = {2025},
  journal = {BMJ Oncol},
  doi = {10.1136/bmjonc-2025-000800},
  url = {https://doi.org/10.1136/bmjonc-2025-000800}
}

RIS

TY  - JOUR
TI  - Chemotherapy and radiotherapy use in patients with lung cancer in Australia, Canada, the UK and Norway 2012-2017: an ICBP population-based study.
AU  - Barclay ME
AU  -  McPhail S
AU  -  Johnson SA
AU  -  Swann R
AU  -  Finley CJ
AU  -  Butler J
AU  -  Alvi R
AU  -  Barisic A
AU  -  Bennett DB
AU  -  Bucher O
AU  -  Creighton N
AU  -  Denny CA
AU  -  Dewar RA
AU  -  Donnelly DW
AU  -  Dowden JJ
AU  -  Downie L
AU  -  Finn N
AU  -  Habbous S
AU  -  Huws DW
AU  -  Kumar SE
AU  -  May L
AU  -  McClure CA
AU  -  Møller B
AU  -  Morrison DS
AU  -  Musto G
AU  -  Nilssen Y
AU  -  Saint-Jacques N
AU  -  Sarker S
AU  -  Shack L
AU  -  Te Marvelde L
AU  -  Tian X
AU  -  Thomas RJ
AU  -  Thomson CS
AU  -  Walton R
AU  -  Wang H
AU  -  Wong THT
AU  -  Woods RR
AU  -  You H
AU  -  Zhang B
AU  -  Lyratzopoulos G
AU  -  ICBP Module 9 Lung Study Group.
PY  - 2025
JO  - BMJ Oncol
DO  - 10.1136/bmjonc-2025-000800
UR  - https://doi.org/10.1136/bmjonc-2025-000800
ER  - 

APA

ME, B., S, M., SA, J., R, S., CJ, F., J, B., R, A., A, B., DB, B., O, B., N, C., CA, D., RA, D., DW, D., JJ, D., L, D., N, F., S, H., DW, H., SE, K., L, M., CA, M., B, M., DS, M., G, M., Y, N., N, S., S, S., L, S., L, T. M., X, T., RJ, T., CS, T., R, W., H, W., THT, W., RR, W., H, Y., B, Z., G, L., & Group., I. M. 9. L. S. (2025). Chemotherapy and radiotherapy use in patients with lung cancer in Australia, Canada, the UK and Norway 2012-2017: an ICBP population-based study.. BMJ Oncol. https://doi.org/10.1136/bmjonc-2025-000800

Source records